Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-324522.64%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -172M | -324522.64% | $ 53K |
| 3/31/2025 | $ -175.8M | -303096.55% | $ 58K |
| 12/31/2024 | $ -162.86M | -266980.33% | $ 61K |
| 9/30/2024 | $ -156.23M | -247987.3% | $ 63K |
| 6/30/2024 | $ -159.01M | -294466.67% | $ 54K |
| 3/31/2024 | $ -160.68M | -236295.59% | $ 68K |
| 12/31/2023 | $ -166.38M | -127984.62% | $ 130K |
| 9/30/2023 | $ -170.57M | -351.67% | $ 48.5M |
| 6/30/2023 | $ -172.58M | -355.98% | $ 48.48M |
| 3/31/2023 | $ -183.99M | -218.53% | $ 84.19M |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) FCF % stands at -2737.94%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average FCF % has been -113138.53%.
- The median FCF % for LYELL IMMUNOPHARMA INC during this period was -2491.1%
- LYELL IMMUNOPHARMA INC reached its highest FCF % over the past 5 years at -218.53%.
- The lowest FCF % recorded by LYELL IMMUNOPHARMA INC in the same timeframe -324522.64%
LYELL IMMUNOPHARMA INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for LYELL IMMUNOPHARMA INC is calculated as follows: FCF [ $ -212.35M ] / Revenues [ $ 7.76M ]
(=) FCF % [ -2737.94% ] LYEL - Free Cash Flow Margin, Last 5 years
-324522.64%
Minimum
Jun 30, 2025
-218.53%
Maximum
Mar 31, 2023
-113138.53%
Average
-2491.1%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.85% |
| median | 7.37% |
| std | 19.48% |